Home >Medication Guide

Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Related Articles

  • Tepotinib-Associated Risk of Liver Function Abnormalities and Liver Failure

    Tepotinib-Associated Risk of Liver Function Abnormalities and Liver FailureTepotinib may cause abnormalities in liver function blood test results, and one patient in clinical trial···【more】
    Article source:Captain MedicineRelease date:2026-06-15Recommended:157

  • Core Mechanism and Indications of Tepotinib

    Core Mechanism and Indications of TepotinibTepotinib is a precision targeted therapy that works by specifically inhibiting the MET protein, which drives cancer growth. By blocking ···【more】
    Article source:Captain MedicineRelease date:2026-06-15Recommended:147

  • Low Blood Sugar Risk and Drug Interactions with Orforglipron

    Low Blood Sugar Risk and Drug Interactions with OrforglipronPatients using Orforglipron need to pay special attention to the risk of hypoglycemia (low blood sugar), especially when···【more】
    Article source:Captain MedicineRelease date:2026-06-12Recommended:160

  • Mechanism of Action of Orforglipron

    Mechanism of Action of OrforglipronThe active ingredient in Orforglipron is orforglipron, which belongs to a class of medications known as GLP-1 receptor agonists. GLP-1 is a natur···【more】
    Article source:Captain MedicineRelease date:2026-06-12Recommended:147

  • Dose Escalation Regimen and Storage Conditions for Orforglipron

    Dose Escalation Regimen and Storage Conditions for OrforglipronWhen using Orforglipron, physicians typically adopt a gradual dose escalation regimen to allow your body adequate tim···【more】
    Article source:Captain MedicineRelease date:2026-06-11Recommended:160

  • Indicated Population and Basic Positioning of Orforglipron

    Indicated Population and Basic Positioning of OrforglipronOrforglipron is a prescription medication clearly indicated for adults with obesity, or for adults who are overweight but ···【more】
    Article source:Captain MedicineRelease date:2026-06-11Recommended:141

  • Managing Skin Side Effects of Mirdametinib

    Managing Skin Side Effects of MirdametinibOne of the most common side effects of Mirdametinib treatment is rash, which may appear as flat rash, raised red bumps, acne-like pimples,···【more】
    Article source:Captain MedicineRelease date:2026-06-10Recommended:153

  • Mirdametinib: Most Common Side Effects in Children

    Mirdametinib: Most Common Side Effects in ChildrenIn pediatric and adolescent patients (ages 2 to 17), the most common side effects of mirdametinib differ somewhat from those in ad···【more】
    Article source:Captain MedicineRelease date:2026-06-10Recommended:161

  • Most common side effects of mirdametinib in adults

    Most common side effects of mirdametinib in adultsAccording to clinical trial data for mirdametinib, the most common adverse reactions in adult patients mainly include five aspects···【more】
    Article source:Captain MedicineRelease date:2026-06-09Recommended:143

  • What is Mirdametinib?

    What is Mirdametinib?Mirdametinib is a prescription medicine specifically used to treat adults and pediatric patients aged 2 years and older who have neurofibromatosis type 1 (NF1)···【more】
    Article source:Captain MedicineRelease date:2026-06-09Recommended:141

  • Effect of Other Drugs on Repotrectinib

    Effect of Other Drugs on RepotrectinibAvoid concomitant use of repotrectinib with P-glycoprotein inhibitors, strong or moderate CYP3A inducers, and strong or moderate CYP3A inhibit···【more】
    Article source:Captain MedicineRelease date:2026-06-05Recommended:196

  • Common Adverse Reactions of Repotrectinib

    Common Adverse Reactions of RepotrectinibThe safety of Repotrectinib was evaluated in 426 patients in the TRIDENT-1 study. Overall, most adverse reactions were Grade 1 or 2, but so···【more】
    Article source:Captain MedicineRelease date:2026-06-05Recommended:203

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

  • Whatsapp

    Name: Lucius

  • Telegram name: Vira

    No.:0085253923643

Lucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved Lucius Pharmaceuticals Lucius Laos 老挝全球药房

WhatsApp

Telegram name: Vira

No.:0085253923643